Arbor Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$449K Hold
3,319
0.1% 38
2021
Q3
$358K Buy
3,319
+900
+37% +$103K 0.08% 37
2021
Q2
$273K Buy
2,419
+187
+8% +$21.1K 0.07% 42
2021
Q1
$242K Buy
2,232
+7
+0.3% +$749 0.07% 39
2020
Q4
$238K Buy
+2,225
New +$214K 0.09% 38
2019
Q3
Sell
-384
Closed -$28K 50
2019
Q2
$28K Buy
+384
New +$30.2K 0.02% 99
2019
Q1
Sell
-600
Closed -$55K 195
2018
Q4
$55K Buy
+600
New +$52.8K 0.05% 71

Other funds holding ABBV

Arbor Wealth Management's ABBV Position: Q4 2021 in Review

Arbor Wealth Management held its AbbVie (ABBV) position steady in Q4 2021 at 3,319 shares worth $449K. The position accounts for 0.1% of the portfolio, ranked #38.

Arbor Wealth Management first reported a position in ABBV in Q4 2018 and has held it in 7 quarters since. 2,982 funds tracked by Wall St. Rank hold ABBV as of Q4 2021.

  • Arbor Wealth Management held 3,319 shares of AbbVie worth $449K as of Q4 2021.
  • Arbor Wealth Management left its AbbVie share count unchanged in Q4 2021.
  • AbbVie made up 0.1% of Arbor Wealth Management's portfolio in Q4 2021, its #38 holding.
  • Arbor Wealth Management first reported a position in AbbVie in Q4 2018 and has held it in 7 quarters since.
  • 2,982 funds tracked by Wall St. Rank held AbbVie as of Q4 2021.

Based on Arbor Wealth Management's 13F filing for Q4 2021, filed 25 Jan 2022.